Benzotropolone inhibitors of estradiol methylation: kinetics and in silico modeling studies

Natural and synthetic benzotropolone compounds were assessed in vitro for their ability to inhibit hydroxyestradiol methylation by catechol-O-methyltransferase (COMT). The compounds were also modeled in silico with a homology model of human COMT. Purpurogallin (1), purpurogallin carboxylic acid (2), and theaflavin-3,3′-digallate (6) were the most potent inhibitors of 2-hydroxy and 4-hydroxyestradiol methylation (IC50 0.22–0.50 μM). Compounds 1 and 6 decreased the Vmax and increased the Km of COMT, indicating a mixed-type inhibition. Compounds 1 and 2 bound to COMT by inserting the six-membered ring of the benzotropolone into the active site. Decreased acidity of the hydroxyl groups on this ring or increased bulkiness reduced potency. Compound 6 bound by inserting the galloyl ester into the active site, which allowed the compound to overcome increased bulkiness and resulted in restored potency. Further studies are needed to determine the impact in vivo of COMT inhibition by these compounds.

Benzotropolone compounds were assessed in vitro and in silico for their ability to inhibit hydroxyestradiol methylation by human catechol-O-methyltransferase (COMT).Figure optionsDownload as PowerPoint slide